Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension

被引:86
|
作者
Dewachter, Laurence
Adnot, Serge
Fadel, Elie
Humbert, Marc
Maitre, Bernard
Barlier-Mur, Anne-Marie
Simonneau, Gerald
Hamon, Michel
Naeije, Robert
Eddahibi, Saadia
机构
[1] Hop Henri Mondor, AP HP, Dept Physiol, F-94010 Creteil, France
[2] Hop Marie Lannelongue, Serv Chirurgie Thorac Vasc & Transplant Cardiopul, UPRES EA 2705, F-92350 Le Plessis Robinson, France
[3] Hop Antoine Beclere, AP HP, Serv Pneumol, Clamart, France
[4] Univ Paris 06, INSERM, Fac Med Pitie Salpetriere, UMR 677, Paris, France
[5] Free Univ Brussels, Fac Med, Physiol Lab, Brussels, Belgium
关键词
angiopoietin-1; growth factors; idiopathic pulmonary arterial hypertension; pulmonary artery smooth muscle; pulmonary endothelial cells;
D O I
10.1164/rccm.200602-304OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Angiopoietins are involved in blood vessel maturation and remodeling. Objectives: One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH). Methods: Ang1, Ang2, and total and phosphorylated Tie2 expression (mRNA and protein) was evaluated in human lung specimens and in cultured pulmonary artery smooth muscle cells (PA-SMCs) and pulmonary endothelial cells (P-ECs) isolated from patients with iPAH and control subjects. Media collected from Ang1-treated P-ECs were assessed for their PA-SMC growth-promoting effect. Measurements and Main Results: Tie2 receptor was fourfold higher in lungs and P-ECs from patients with iPAH than in those from control subjects, with a parallel increase in phosphorylated lung Tie2 receptor. In contrast, Ang1 and Ang2 expression in lungs, P-ECs, and PA-SMCs did not differ. Incubation of PA-SMCs with medium collected from P-EC cultures induced marked proliferation, and this effect was stronger when using P-ECs from patients with iPAH than from control subjects. Ang1 pretreatment of P-ECs from either patients or control subjects induced a further increase in PA-SMC proliferation. Fluoxetine, an inhibitor of the mitogenic action of serotonin, reduced the growth-promoting effect of P-EC media. Ang1 added to P-ECs from patients with iPAH increased the production of endothelin-1 (ET-1) and serotonin, but not of plateletderived growth factor-BB orepidermal growth factor, and increased the amount of mRNA encoding tryptophan hydroxylase-1 (the rate-limiting enzyme of serotonin synthesis), preproET-1, and ET-11-converting enzyme. Conclusions: The Ang1/Tie2 pathway is potentiated in iPAH, contributing to PA-SMC hyperplasia via increased stimulation of endothelium-derived growth factors synthesis by P-ECs.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 50 条
  • [21] Angiopoietin-1 Augments Vasculogenic Potential Through Tie2/Ets-1 Pathway
    Kwon, Yoo-Wook
    Cho, Hyun-Jai
    Kim, Min-Seok
    Kim, Jy-Young
    Lee, Choon-Soo
    Yang, Han-Mo
    Kim, Hyo-Soo
    Park, Young-Bae
    CIRCULATION RESEARCH, 2009, 105 (07) : E23 - E23
  • [22] Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice
    Lin, Yiming
    Mcclennan, Andrew
    Hoffman, Lisa
    BIOMEDICINES, 2023, 11 (08)
  • [23] Vascular Smooth Muscle Cell-expressed Tie2 Controls Atherosclerosis Progression
    Kapel, Stephanie S.
    Shi, Jingjing
    Hasanov, Zulfiyya
    Appak-Baskoy, Sila
    Singhal, Mahak
    Wojtarowicz, Jessica
    Hertel, Stella
    Krunic, Damir
    Korn, Claudia
    Hu, Junhao
    Arnold, Caroline
    Robciuc, Marius
    Korff, Thomas
    Augustin, Hellmut G.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [24] Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization
    Bogdanovic, Elena
    Nguyen, Vicky P. K. H.
    Dumont, Daniel J.
    JOURNAL OF CELL SCIENCE, 2006, 119 (17) : 3551 - 3560
  • [25] Role of Angiopoietin/Tie2 System in Sepsis: A Potential Therapeutic Target
    Chi, Yawen
    Yu, Sihan
    Yin, Jia
    Liu, Danyan
    Zhuo, Mengke
    Li, Xu
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [26] THERAPEUTIC MODULATION OF THE ANGIOPOIETIN/TIE2 SYSTEM IN MURINE EXPERIMENTAL SEPSIS
    Stiehl, T.
    Thamm, K.
    Schaeper, U.
    Kaufmann, J.
    Santel, A.
    Haller, H.
    David, S.
    INTENSIVE CARE MEDICINE, 2013, 39 : S500 - S501
  • [27] The Angiopoietin/Tie2 Axis Mediates Malignant Pleural Effusion Formation
    Moschos, Charalampos
    Psallidas, Ioannis
    Kolintza, Androniki
    Karabela, Sophia
    Papapetropoulos, Andreas
    Papiris, Spiros
    Light, Richard W.
    Roussos, Charis
    Stathopoulos, Georgios T.
    Kalomenidis, Ioannis
    NEOPLASIA, 2009, 11 (03): : 298 - 304
  • [28] Cyclic peptide agonist for the angiopoietin-1 receptor (TIE2)
    Ogbede, Joseph Uche
    D'Amato, Robert J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [29] Regulation of Tie2 expression by angiopoietin-potential feedback system
    Hashimoto, T
    Wu, YQ
    Boudreau, NJ
    Li, JF
    Matsumoto, MM
    Young, WL
    ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2004, 11 (3-4): : 207 - 210
  • [30] Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
    Maisonpierre, PC
    Suri, C
    Jones, PF
    Bartunkova, S
    Wiegand, S
    Radziejewski, C
    Compton, D
    McClain, J
    Aldrich, TH
    Papadopoulos, N
    Daly, TJ
    Davis, S
    Sato, TN
    Yancopoulos, GD
    SCIENCE, 1997, 277 (5322) : 55 - 60